Taken together, our results indicate that ABC transporters have a specific and direct role in cancer by releasing bioactive signalling molecules, and therefore their inhibition could be beneficial not only to prevent or oppose drug resistance but also to reduce cancer progression, especially in combination with chemotherapeutics. The gene discussed is ABCG2; the disease is cancer.